Proactive Investors - Run By Investors For Investors

Redx Pharma Plc RNS Release

Notice of Annual General Meeting

RNS Number : 9767B
Redx Pharma plc
07 April 2017

7 April 2017



("Redx" or "the Company")


Notice of Annual General Meeting


Redx Pharma, the research and development company focused on cancer, immunology and infection, announces that its Annual General Meeting will be held at 9.30am on 20 April 2017 at Redx Pharma Plc, Mereside, Alderley Park, Macclesfield SK10 4TG, UK.


Following the announcement of preliminary results for the financial year ended 30 September 2016 on 21 March, the Company announces that the Annual Report and Accounts and notice of Annual General Meeting have now been posted to shareholders. The Annual Report and Accounts is also available to view on Redx's website at


For further information, please contact:


Redx Pharma Plc


Neil Murray, Chief Executive Officer

T: +44 1625 469 900 

Karl Hård, Head of Investor Relations &

Corporate Communications

T: +44 7491 651 406


Cantor Fitzgerald Europe (Nomad & Broker)


T: +44 20 7894 7000

Phil Davies/ Michael Reynolds




WG Partners LLP (Joint Broker)

        T: +44 20 3705 9330

Claes Spång/ Chris Lee/ David Wilson



Consilium Strategic Communications

      T: +44 20 3709  5700                                        

Amber Fennell/ Matthew Neal/ Melissa Gardiner    



About Redx Pharma Plc

Company website: 

Redx is focused on the discovery and development of proprietary, small molecule therapeutics to address areas of high, unmet medical need, principally in cancer, immunology and infection providing a pipeline of assets to larger and emerging companies. By improving the characteristics of existing drug classes to create highly differentiated, novel, best-in-class drugs, Redx has already established a broad portfolio of proprietary drug programs.



This information is provided by RNS
The company news service from the London Stock Exchange

Redx Pharma Plc Timeline

CN Research
April 06 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use